Hospice News February 23, 2024
Amedisys (NASDAQ: AMED) is pushing forward on palliative care growth in 2024 through its innovation arm, Contessa.
The company acquired Contessa in 2021 for $250 million. Contessa’s specialties are high-acuity care in the home, including hospital-at-home and skilled nursing facility-at-home programs. Nevertheless, the company has been making substantial investments in building out its palliative care services, particularly through risk-based contracts.
For now, Amedisys shows no signs of slowing down on palliative care. Expanding palliative care relationships and joint venture partnerships is a priority for 2024, the Louisiana-based home health and hospice provider indicated in a filing with the U.S. Securities and Exchange Commission (SEC).)
“Our expertise and capabilities in these areas deliver value to both the health system and the...
Today's Sponsors
Today's Sponsor